[PDF][PDF] Type I IFN immunoprofiling in COVID-19 patients
…, A Gaymard, S Pons, JC Richard, M Perret… - Journal of Allergy and …, 2020 - Elsevier
Funding-Quanterix provided the kits for this study free of charge. 37 Conflict of interest–Pons
S, Oriol G, Brengel-Pesce K, Mouton W, Compagnon C are Biomérieux® 38 employeers. …
S, Oriol G, Brengel-Pesce K, Mouton W, Compagnon C are Biomérieux® 38 employeers. …
Inborn errors of OAS–RNase L in SARS-CoV-2–related multisystem inflammatory syndrome in children
…, E Talouarn, D Rinchai, P Zhang, M Perret… - Science, 2022 - science.org
Multisystem inflammatory syndrome in children (MIS-C) is a rare and severe condition that
follows benign COVID-19. We report autosomal recessive deficiencies of OAS1, OAS2, or …
follows benign COVID-19. We report autosomal recessive deficiencies of OAS1, OAS2, or …
[PDF][PDF] The staphylococcal toxin Panton-Valentine Leukocidin targets human C5a receptors
AN Spaan, T Henry, WJM Van Rooijen, M Perret… - Cell host & …, 2013 - cell.com
Panton-Valentine Leukocidin (PVL) is a staphylococcal bicomponent pore-forming toxin
linked to severe invasive infections. Target-cell and species specificity of PVL are poorly …
linked to severe invasive infections. Target-cell and species specificity of PVL are poorly …
Polyclonal expansion of TCR Vβ 21.3+ CD4+ and CD8+ T cells is a hallmark of multisystem inflammatory syndrome in children
…, S Djebali, A Bellomo, O Dauwalder, M Perret… - Science …, 2021 - science.org
Multisystem inflammatory syndrome in children (MIS-C) is a delayed and severe complication
of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection that strikes …
of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection that strikes …
The impact of dual viral infection in infants admitted to a pediatric intensive care unit associated with severe bronchiolitis
…, F Komurian-Pradel, E Javouhey, M Perret… - The Pediatric …, 2008 - journals.lww.com
Objective: To investigate the relevance of dual viral infection in infants with severe bronchiolitis
hospitalized in a short-term unit compared with those in a pediatric intensive care unit (…
hospitalized in a short-term unit compared with those in a pediatric intensive care unit (…
Type I IFN signaling constrains IL-17A/F secretion by γδ T cells during bacterial infections
…, T Ruby, JW Jones, K Peng, M Perret… - The Journal of …, 2010 - journals.aai.org
Recognition of intracellular bacteria by macrophages leads to secretion of type I IFNs.
However, the role of type I IFN during bacterial infection is still poorly understood. Francisella …
However, the role of type I IFN during bacterial infection is still poorly understood. Francisella …
Antibodies against type I interferon: detection and association with severe clinical outcome in COVID‐19 patients
…, M Mezidi, P Bastard, M Perret… - Clinical & …, 2021 - Wiley Online Library
Objectives Impairment of type I interferon (IFN‐I) immunity has been reported in critically ill
COVID‐19 patients. This defect can be explained in a subset of patients by the presence of …
COVID‐19 patients. This defect can be explained in a subset of patients by the presence of …
Cross‐talk between Staphylococcus aureus leukocidins‐intoxicated macrophages and lung epithelial cells triggers chemokine secretion in an inflammasome …
M Perret, C Badiou, G Lina, S Burbaud… - Cellular …, 2012 - Wiley Online Library
Staphylococcus aureus is a major pathogen responsible for both nosocomial and
community‐acquired infections. Central to its virulence is its ability to secrete haemolysins, pore‐…
community‐acquired infections. Central to its virulence is its ability to secrete haemolysins, pore‐…
Severe COVID-19 patients have impaired plasmacytoid dendritic cell-mediated control of SARS-CoV-2
Type I and III interferons (IFN-I/λ) are important antiviral mediators against SARS-CoV-2
infection. Here, we demonstrate that plasmacytoid dendritic cells (pDC) are the predominant IFN-…
infection. Here, we demonstrate that plasmacytoid dendritic cells (pDC) are the predominant IFN-…
Refining “Long-COVID” by a prospective multimodal evaluation of patients with long-term symptoms attributed to SARS-CoV-2 infection
…, R Carapito, S Trouillet-Assant, M Perret… - Infectious diseases and …, 2021 - Springer
… Sabrina Bibi-Triki, Raphael Carapito, Sophie Trouillet-Assant, Magali Perre, Alexandre
Belot and Seiamak Bahram conducted the immunologic assays (cytokines). … Magali Perret …
Belot and Seiamak Bahram conducted the immunologic assays (cytokines). … Magali Perret …